Home > Insider Trading > Filing (0001140361-15-042172)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238403	K Daniel Spiegelman	C/O Biomarin Pharmaceutical Inc., 770 Lindaro St. San Rafael CA 94901	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-11-16	20,000	$39.06	48,229	No	4	M	Direct
Common Stock	Disposition	2015-11-16	20,000	$104.30	28,229	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2015-11-16	20,000	$0.00	20,000	$39.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,500	2012-11-29	2022-05-28	No	4	M	Direct

Footnotes

Trade made pursuant to a 10b5-1 plan executed on September 14, 2015.
The price in column 4 is a weighted average price. The price actually received ranged from $102.98 to $107.57. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Original option grant vests 6/48ths on November 29, 2012, and 1/48th on the 29th day of every month thereafter.
Reflects the number of stocks options that remain outstanding from this specific stock option grant following the reported transaction.